Midokalm - injections

The drug "Midokalm" (injections) is available in the form of a solution. The agent may be colorless or have a slightly greenish tinge. "Midokalm" (injections) has a specific smell. There are no mechanical inclusions in the solution.

Active ingredients: lidocaine, Tolperisone.

Auxiliary components: water, diethylene glycol monoethyl ether, methyl paraben.

"Midokalm" (injections) is included in the group of muscle relaxants of central action. The drug has a local anesthetic, as well as a membrane-stabilizing property. The medication has the ability to inhibit the impulse conductivity of the primary afferent fibers and motor neurons. This leads to blocking in the spinal cord of polysynaptic and monosynaptic reflexes.

"Midokalm" is able to increase blood flow (peripheral) regardless of the central nervous system. The formation of this property is due to the weakly expressed adrenoblocking and spasmolytic effect of the active component of tolperisone.

"Midokalm" (injections). Instructions. Indication.

The drug is prescribed in the treatment of muscle spasms, contractures and increased tone accompanying the pathology of the motor system. Diseases, in particular, include spondylarthrosis, spondylosis, arthrosis in large joints and others. Also, "Midokalm" (injections) is indicated for the therapy of pathologically increased muscle tone and spasms in the striated muscles, caused by organic diseases of the central nervous system. Such pathologies include multiple sclerosis, encephalomyelitis, stroke, damage in the pyramidal ways, myelopathy.

The medication is also used for restorative therapy after traumatological and orthopedic interventions.

The drug is included in the combined treatment of obliterating vascular lesions (diabetic angiopathy, Raynaud's disease and others), as well as pathologies that resulted from a disorder in the innervation of blood vessels (acrocyanosis and others).

Midokalm. Instructions for use

The injections are prescribed to adults intramuscularly twice a day for one hundred milligrams. Slow intravenous administration once a day in the above dosage is acceptable.

As adverse events, vomiting, stomach discomfort, headache, weakness in the muscles, hypotension (arterial) are possible . As a rule, with a decrease in the dosage of the drug administered, the undesired reactions pass.

In some cases, itching, hives, anaphylactic shock, erythema may occur.

No medication is prescribed for myasthenia gravis, in childhood, and also for hypersensitivity to the components of the drug. During lactation, during the first trimester of the prenatal period, the expediency of using the medication is allowed on the prescription of the doctor.

Midokalm does not have a negative impact on the ability to drive and carry out activities that involve increased concentration of attention and a high rate of psychomotor reactions.

Cases of overdose in practice are described insufficiently. However, according to the results of animal studies, when oral medication "Midokalm-Richter" was administered in increased doses, there was ataxia, respiratory paralysis, dyspnea, tonic convulsions. Specific antidote is not developed. It is recommended to treat overdose on the basis of symptoms (symptomatic).

Despite the fact that tolperisone is able to have an effect on the central nervous system, it does not have a sedative effect. In this regard, its use in combination with hypnotics, sedatives containing ethanol is allowed.

From drugstores the drug is released on the basis of the prescription. Shelf life of the medication is three years.